ClinicalTrials.gov
public full text
Public Domain
Nutrition Product Combine With Continuous Glucose Monitoring in Gestational Diabetes Mellitus Patients
A prospective, multicenter, randomized controlled trial including about 60 Gestational Diabetes Mellitus patients (GDM) in Beijing will be included to evaluate the effectiveness and safety of nutrition product (SANZ®KINGWILL) in GDM patients, based on Continuous Glucose Monitoring (San MediTech CGM-303).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Daily Versus Every Other Day Glucose Monitoring in Gestational Diabetes Mellitus#850801
- Postpartum Diabetes Screening in Women With Gestational Diabetes#894169
- Pilot Study of Continuous Glucose Monitoring for Postpartum Glucose Screening#1088498
- Glyburide and Metformin for Gestational Diabetes Mellitus (GDM)#1151280
- Tolerability, Acceptance, and Utility of Intermittent CGM Use in Youth With Prediabetes#830664
Record · ID 850886
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive